Bio-Me logo
Bio-Me
23andMe for the gut microbiome
Oslo, Norway
0 Upvotes
35 Views
Healthcare
0 Upvotes


35 Views

ABOUT

Company details
YEAR FOUNDED
2016
EMPLOYESS
Myself
FUNDING STAGE
Seed
GROWTH STAGE
Early growth
BUSINESS TYPE
B2B, B2C
REVENUE STATUS
Pre revenue
FUNDING NEEDS
10-15 MNOK
FUNDING TO DATE
< 1 MNOK
Oslo, Norway
About

Bio-Me is disrupting the healthcare industry, by developing GutCheck™, a rapid, high throughput, low-cost gut microbiome analysis platform, with the same level of detail as whole genome sequencing. The GutCheck™ test, together with instant access to tens of thousands of patient samples from HUNT4 (NTNU), including extensive genetic, life-style and medical information, will make it possible for Bio-Me to build up a world-class database with machine learning capabilities, in order to provide superior insights and knowledge about the effect of the gut microbiome on health and disease to the general population and medical professionals, as well as to the Pharma and Food industry in Precision Medicine and Personalized Nutrition.

Key customerPharmaceutical and Food companies, people with interest in or has gut health challanges.
Unique selling pointsRapid, detailed, high throughput and low cost gut microbiome analysis, important for Precision Medicine and Personalized Nutrition.
JobsBio-Me is currently not hiring. Please check back later for job openings!